Saints or Saviors? Secondary Buyers Offer Exit for BSX, Others
This article was originally published in Start Up
Executive Summary
Following the sale of Boston Scientific's venture portfolio, secondary buyers are positioning themselves as possible purchases of venture capital portfolios.